Clinical Study of Patients with Hypertriglyceridemia (thyroglobulin from 5,6 mmol/L to 22,6 mmol/L)

Clinical Research Center «BioEq» invites patients to participate in the phase III clinical study of the drug for treatment of patients with the level of triglycerides when fasted within the limits of 5,6  mmol/L- 22,6 mmol/L.  

Investigational Product: original drug, the PPAR agonist (tablets)

Research Duration: 1 year. During the first 4 month, patients shall visit the center once per month, afterwards once in 2,5 months.

All examinations and medications are provided on a free of charge basis. «BioEq» provides taxi for all visits, except the first one. 

We invite men and women starting from 18 years old with:

  •          Atherosclerotic cardiovascular disease 

If you are interested in this research or you have questions about participation, you can contact us during the business days from 10 am to 6 pm at  8-812-945-22-32